MetLife (MET) Expected to Announce Quarterly Earnings on Wednesday

MetLife (NYSE:MET) is projected to issue its quarterly earnings data after the market closes on Wednesday, February 5th. Analysts expect the company to announce earnings of $2.13 per share and revenue of $19.49 billion for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

MetLife Stock Down 1.2 %

Shares of NYSE MET opened at $85.48 on Tuesday. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a fifty day moving average price of $84.06 and a 200 day moving average price of $80.54. The company has a market cap of $59.18 billion, a P/E ratio of 17.23, a P/E/G ratio of 0.66 and a beta of 1.07. MetLife has a 12-month low of $64.61 and a 12-month high of $89.05.

MetLife Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be paid a $0.545 dividend. The ex-dividend date is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.55%. MetLife’s payout ratio is currently 43.95%.

Analyst Ratings Changes

MET has been the topic of a number of research analyst reports. Barclays raised their price objective on shares of MetLife from $90.00 to $96.00 and gave the company an “overweight” rating in a research note on Monday, January 6th. BMO Capital Markets initiated coverage on shares of MetLife in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 price objective for the company. Wells Fargo & Company decreased their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating for the company in a research note on Tuesday, January 14th. StockNews.com lowered shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, JPMorgan Chase & Co. raised their price target on shares of MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a report on Tuesday, January 7th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. Based on data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and an average target price of $90.46.

MetLife Company Profile

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.